Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe/ mice
In these trials, around 3,800 patients aged between 55 and 85 with a confirmed diagnosis and mild symptoms received up to 14 mg daily of oral semaglutide or a placebo
Recommended protocol: Washout: 20 to 25 days Starting dose: 1mg weekly Week 5: escalate to 2mg Week 9: escalate to 4mg Week 13: escalate to 8mg Week 17: consider 12mg based on response and tolerance This protocol follows the standard retatrutide peptide dosage chart exactly, treating you similarly to a GLP-1 naive individual
Adverse Reactions in a Clinical Trial of Pediatric Patients Aged 12 Years and Older with Obesity WEGOVY was evaluated in a 68-week, double-blind, randomized, parallel group, placebo-controlled, multi-center trial in 201 pediatric patients aged 12 years and older with obesity [see Clinical Studies (14.3)]
While you can technically stop tirzepatide immediately without physical harm from withdrawal, the metabolic and weight-related consequences of stopping require careful consideration and planning
If you are struggling with the current schedule, the safest next step is to communicate with your clinical team